small cell lung cancer
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
small cell lung cancer
Jul 25, 2024, 06:32 |
Insight
Stephen Liu: Novel epigenomic cfDNA approach in diagnosis of EGFR mutant NSCLC
Stephen Liu shared a post on X about a recent paper by Jacob E. Berchuck…
Jul 25, 2024, 00:36 |
Blog
Diana Romero: AI, exploiting bacteria, multiple myeloma and more in the new issue of Nature Reviews Clinical Oncology
Diana Romero, Chief Editor at Nature Research, shared on LinkedIn: "A new issue of Nature…
Jul 11, 2024, 13:02 |
Blog
Eric Singhi: Clinical updates for patients with small cell lung cancer
Eric Singhi shared a post by Oncology Brothers on X, adding: "Always a great time…
Jul 5, 2024, 02:47 |
Drugs
A new standard for treating limited-stage small cell lung cancer - Sarah Cannon Research Institute
Sarah Cannon Research Institute shared on LinkedIn: "Dr. David R. Spigel recently shared research on durvalumab…
Jun 18, 2024, 06:26 |
Blog
Chul Kim: Dr. Jacob Zaemes, BIDMC is lucky to have you
Chul Kim shared on X: "Big congrats to my mentee, Dr. Jacob Zaemes, on his…
Jun 14, 2024, 16:23 |
Societies
ASCO issued a rapid guideline update on systemic therapy for SCLC
ASCO shared on X: "We’ve issued a rapid guideline update on systemic therapy for SCLC.…
Jun 8, 2024, 16:06 |
Blog
Reflections on ASCO24 by Jill Feldman
Jill Feldman shared on X/Twitter: "1. What an honor to meet Dr. Lynn Schuchter. I'm grateful…
Jun 8, 2024, 11:29 |
Insight
Key Insights You Don't Want to Miss - The Babak Lab
The Babak Lab shared on LinkedIn: "Weekly Digest: Key Insights You Don't Want to Miss!…
Jun 4, 2024, 03:22 |
Blog
Vivek Subbiah: Our amazing CSO Dr. Spigel will be presenting at the big plenary!
Vivek Subbiah shared on X/Twitter: "ASCO24 Sunday morning! Starting the day with Skip Burris, Conquer Cancer,…
Jun 2, 2024, 13:01 |
Blog
Moffitt Cancer Center is the first healthcare provider in the US to commercially administer a newly-approved therapy for Small Cell Lung Cancer
Moffitt Cancer Center shared on their X/Twitter: ''Moffitt is the first healthcare provider in the…
Jun 1, 2024, 15:59 |
Immune Oncology
Immunotherapy for Lung Cancer
Lung cancer and immunotherapy Lung cancer is the leading cause of cancer-related deaths worldwide, with…
May 31, 2024, 07:45 |
Insight
Aakash Desai: ASCO24 set to showcase some SCLC research, hopefully pushing boundaries in this field
Aakash Desai, Assistant Professor at O’Neal Comprehensive Cancer Center at UAB, shared on LinkedIn: “T-2 ASCO24…
May 20, 2024, 14:10 |
Blog
Analysis of SCLC transcriptional factor subtypes finds differential CNS-specific outcomes - Memorial Sloan Kettering Radiation Oncology
Memorial Sloan Kettering Radiation Oncology made the following post on X: New by Dr. Kathryn…
May 20, 2024, 13:49 |
Opinion
Amy Moore: BIG DEAL for those living with small cell lung cancer
Amy Moore, VP of Global Engagement and Patient Partnerships, LUNGevity Foundation, shared a post by LUNGevity…
May 19, 2024, 10:55 |
Insight
Dhruba Deb: The 8 SCLC projects Lung Cancer Research Foundation recently funded
Dhruba Deb, Senior Director of Research and Administration at Lung Cancer Research Foundation, shared on…
May 18, 2024, 02:46 |
Drugs
Vivek Subbiah: US FDA granted accelerated approval to tarlatamab-dlle
Vivek Subbiah shared on X: "New FDA Approval. Today the US FDA granted accelerated approval…
May 15, 2024, 09:38 |
Blog
Tanja Obradovic: Important PDUFA on June 12th is coming up
Tanja Obradovic shared a post on LinkedIn: "Important PDUFA on June 12th is coming up that…
May 9, 2024, 14:13 |
Insight
Jarushka Naidoo: Interesting multi-omic analysis of previously classified SCLC cell lines
Jarushka Naidoo shared a post on X: “Interesting multi-omic analysis of previously classified Small Cell Lung…
May 6, 2024, 07:50 |
Blog
Marcus Skribek: I will be joining MSKCC as a Research Fellow
Marcus Skribek shared a post on LinkedIn: "I'm delighted to announce that I will be joining…
May 2, 2024, 11:03 |
Blog
Yonghao Yu: PARP inhibitiors for SCLC
Yonghao Yu, Professor of Molecular Pharmacology and Therapeutics at Columbia University Irving Medical Center, shared a…
Apr 26, 2024, 20:26 |
Insight
New Paper Alert! Liposomal Irinotecan vs Topotecan for Relapsed Small Cell Lung Cancer: RESILIENT Phase 3 Trial
Liposomal Irinotecan vs Topotecan for Relapsed Small Cell Lung Cancer: RESILIENT Phase 3 Trial Authors:…
Apr 25, 2024, 12:40 |
Drugs
Piotr Wysocki: Similar activity of topotecan and liposomal irinotecan in second-line treatment of SCLC
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 9, 2024, 09:26 |
Blog
Misty Dawn Shields: Thank you to the Indiana University Graduate School Bloomington Medical Molecular Genetics program for the invitation to speak at the seminar series on Shields Lab research
Apr 8, 2024, 16:20 |
Drugs
Rami Manochakian: BIG NEWS press release by AstraZeneca!
Rami Manochakian, Thoracic Medical Oncologist at Mayo Clinic, shared a post on X: “Hot Off…
Apr 8, 2024, 14:26 |
Insight
Shubh Goel: ADRIATIC Phase III trial for LS-SCLC couldn’t come at a more critical time for patients
Shubh Goel, VP and US Franchise Head, Immuno-Oncology and GI Tumors at AstraZeneca, shared a post…
Apr 5, 2024, 15:22 |
Insight
Eric Singhi: NEW phase 3 study activated at MD Anderson Cancer Center for patients with limited-stage small cell lung cancer
Eric Singhi, Thoracic Medical Oncologist at MD Anderson Cancer Center, recently posted on X: "NEW…
Apr 2, 2024, 05:10 |
Blog
Chul Kim: March has been fruitful and rewarding, as we launched two IITs of ADC back to back!
Chul Kim, Thoracic Medical Oncologist at Georgetown University, shared on X/Twitter: "March has been fruitful…
Feb 26, 2024, 11:16 |
Insight
Henry Rodriguez: Unraveling the mysteries of small cell lung cancer
Henry Rodriguez, Founding Director of the Office of Cancer Clinical Proteomics Research at the NCI,…
Feb 10, 2024, 15:51 |
Drugs
Vivek Subbiah: Pleased to share my thoughts on Lurbinecredin data in small cell lung cancer
Vivek Subbiah shared a post on LinkedIn: “Pleased to share my thoughts on Lurbinecredin data…
Jan 8, 2024, 14:29 |
Blog
Stephen V Liu: I discuss managing relapsed Small-Cell Lung Cancer with Fiona Blackhall and Misty Dawn Shields
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at the Lombardi Comprehensive Cancer…
Oct 14, 2023, 18:23 |
Blog
Rami Manochakian: NEW ASCO and Ontario Health Guideline on Systemic Therapy for Small Cell Lung Cancer.
Rami Manochakian, Thoracic medical oncologist at Mayo Clinic, shared on X/Twitter: "Hot off the press…
Aug 28, 2023, 17:40 |
Insight
Vivek Subbiah: Lurbinectedin was approved for Small cell Lung in USA and now is also approved in Canada, Australia, Singapore, the United Arab Emirates, Qatar, South Korea, Ecuador, Mexico, Israel and Switzerland.
All:
32
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube